Report overview
HIV Screening Machine is a set of blood tests used to detect infection with the human immunodeficiency virus (HIV) in serum, saliva or urine. Such tests may diagnose HIV antibodies, antigens or RNA.
This report aims to provide a comprehensive presentation of the global market for HIV Screening Machines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HIV Screening Machines. This report contains market size and forecasts of HIV Screening Machines in global, including the following market information:
Global HIV Screening Machines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global HIV Screening Machines Market Sales, 2018-2023, 2024-2029, (Units)
Global top five HIV Screening Machines companies in 2022 (%)
The global HIV Screening Machines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Rapid Immunoassay Test Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of HIV Screening Machines include Roche, Siemens, Danaher, Abbott Laboratories, Bio-Rad Laboratories, AccuBioTech, BioMerieux, Qiagen and Meridian Bioscience, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the HIV Screening Machines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global HIV Screening Machines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global HIV Screening Machines Market Segment Percentages, by Type, 2022 (%)
Rapid Immunoassay Test
Rapid Molecular Diagnostic Test
Global HIV Screening Machines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global HIV Screening Machines Market Segment Percentages, by Application, 2022 (%)
Hospitals
Laboratories
Others
Global HIV Screening Machines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global HIV Screening Machines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies HIV Screening Machines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies HIV Screening Machines revenues share in global market, 2022 (%)
Key companies HIV Screening Machines sales in global market, 2018-2023 (Estimated), (Units)
Key companies HIV Screening Machines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Siemens
Danaher
Abbott Laboratories
Bio-Rad Laboratories
AccuBioTech
BioMerieux
Qiagen
Meridian Bioscience
Hologic
Creative Diagnostics
Outline of Major Chapters:
Chapter 1: Introduces the definition of HIV Screening Machines, market overview.
Chapter 2: Global HIV Screening Machines market size in revenue and volume.
Chapter 3: Detailed analysis of HIV Screening Machines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of HIV Screening Machines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global HIV Screening Machines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
